coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    The Havens PCN, Lewes · Health Inequalities Profile

    PCN U21317 · NHS Surrey and Sussex Integrated Care Board; NHS Sussex Integrated Care Board · 3 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    36,166

    Registered population

    58.0% aged 18–64

    22.3%

    Aged 65+

    ICB 21.9% · England 17.9%

    7.3%

    Ethnic minority (non-White)

    2.6% Asian · England 9.6%

    4.3%

    In IMD quintile 1

    ICB 9.2% · England 21.0%

    ~1,426

    Core20 residents (est.)

    Resident basis; registered basis ~1,680 · see page 3

    6,479

    Hypertension register

    +4.43% in 3 yrs · England +5.60%

    517

    SMI register

    40.8% of Lewes'

    905

    COPD register

    Reviews +56.26% in 3 yrs

    Forecast to 2030

    7,425

    Hypertension patients, 2030

    +946 on today

    63.9%

    QRISK ≥20% on statins, 2030

    +3.45pp over 3 yrs

    5.5%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    56.3%
    CVD treatment to target lags England.

    QRISK >= 20% lipid therapy is 56.3% (England 63.6%) and hypertension treatment to target is 64.6% (England 70.3%), which may reflect unescalated therapy.

    -11.1%
    Dementia and stroke registers contracted over 2023-2025.

    Dementia prevalence changed -11.1% (England +6.0%) and stroke -1.0% (England +2.3%) over 2023 to 2025, which could reflect unverified coding or case-finding gaps.

    +74.7%
    Respiratory reviews and BP control rose strongly.

    Over 2023 to 2025, asthma reviews rose +74.7% (England +4.4%), COPD reviews rose +56.3% (England +2.8%), and under-80 BP control rose +9.3 pp.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Older residents comprise 22.3% of the PCN, exceeding England's 17.9% list share

    Across 36,166 registered patients, 22.3% are aged 65+, below Lewes (25.9%) but above NHS Sussex Integrated Care Board (21.9%) and England (17.9%). Children aged 0-17 comprise 19.7% (Lewes 17.7%, NHS Sussex Integrated Care Board 17.7%, England 19.6%). Census resident ethnicity, which reflects catchment areas rather than registered lists, is 92.7% White (Lewes 94.2%, NHS Sussex Integrated Care Board 91.0%, England 81.1%) and 2.6% Asian / Asian British (Lewes 1.9%, NHS Sussex Integrated Care Board 3.7%, England 9.6%). Primary list size is projected to grow 3.0% by 2030 (Lewes 2.3%, NHS Sussex Integrated Care Board 2.1%, England 2.3%), under unverified methodology.

    Age profile

    0–1719.7%
    18–6458.0%
    65+22.3%

    65+: ICB 21.9%, England 17.9%

    Ethnicity

    White92.7%
    Mixed2.6%
    Asian2.6%
    Other1.1%
    Black1.0%

    Older people · falls rows are Lewes local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Lewes LA)2,3592,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)80.0%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)56.3%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Lewes LA)1,1119819552024/25
    Falls deaths, all ages, per 100,000 (Lewes LA)15.214.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Deprivation is concentrated in two practices while PCN Core20 is 4.3%

    The PCN average IMD decile is 4.4 (Lewes 6.2, England 5.5). The PCN Core20 share is 4.3% (Lewes 2.9%, England 21.0%), while weighted practice Core20 is 4.6% (a 0.36 pp reconciliation difference). Practice distribution spans an 11.4 pp range: Chapel Street Surgery has the highest concentration at 11.4% (estimated 576 patients), while Quayside Medical Practice holds the largest volume at 9.2% (estimated 1,104 patients). Havenshealth records 0.0%.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Chapel Street11.4% · 576 patients
    Quayside Medical9.2% · 1,104 patients
    Havenshealth0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    517

    SMI register

    1.42% recorded prevalence

    232

    Learning disability register

    0.64% recorded prevalence

    10

    Care homes, 161 beds

    In the PCN catchment

    9.9%

    Provide unpaid care

    Lewes, Census 2021

    The PCN records 517 patients on the severe mental illness register (1.4% vs Lewes 1.4%, NHS Sussex Integrated Care Board 1.1%, England 1.0%), accounting for 40.8% of the borough register, and 232 on the learning disability register (0.6%). The PCN catchment includes 10 care homes with 161 beds.

    Severe mental illness: physical health checks

    SMI blood pressure recording reached 86.3% (England 83.4%), while BMI recording was 81.8% (England 82.1%) and smoking cessation support was 90.4% (England 94.2%). At Chapel Street Surgery, recorded BMI checks were 58.0%.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    6,479

    Hypertension register

    +4.43%

    Register growth, 3 yrs

    Lewes +5.23% · England +5.60%

    +9.27pp

    BP control, under 80

    ≤140/90 · +5.89pp aged 80+

    +946

    More patients by 2030

    Forecast 7,425 (19.36%)

    Hypertension case-finding and control

    Hypertension register prevalence is 17.8% (6,479 patients), above England (15.2%) and NHS Sussex Integrated Care Board (16.3%), but below Lewes (18.1%). Recent blood pressure recording reached 89.5% (England 90.0%). Blood pressure control among patients aged under 80 improved by +9.3 pp over three years (England +2.1 pp) to 65.1%, though it remains below England (67.8%) and varies from 59.2% at Chapel Street Surgery to 67.7% at Havenshealth. Observation periods were not supplied for recorded prevalence. Lower blood pressure control than national benchmarks suggests an opportunity to prioritise systematic medication titration and recall across practices trailing the England rate.

    Lipids and statins

    For patients with QRISK ≥ 20%, 56.3% receive lipid-lowering therapy, in line with Lewes (56.2%) but below England (63.6%) and NHS Sussex Integrated Care Board (60.0%). Fewer at-risk primary prevention patients receive lipid-lowering therapy than national rates imply, presenting an opportunity to prioritise proactive treatment reviews for high-risk cohorts.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202661,651£2.50£2.42£1.86£154,128
    Cardiovascular (all), 202588,235£3.20£3.32£3.33£282,352

    In 2026, lipid-modifying drugs cost £2.50 per item across 61,651 items, compared to £2.34 in Lewes, £2.42 in NHS Sussex Integrated Care Board, and £1.86 in England, which is £39,457 more than at England's unit cost. Higher unit cost than national benchmarks highlights an opportunity to audit formulary choices and switch to cost-effective lipid-modifying regimens.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +74.65%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +1.61%

    Asthma prevalence, PCN 3-yr % change

    Asthma reviews rose +74.7% over three years (England +4.4%) to 65.5% (England 65.7%, Lewes 57.0%), leaving an estimated 945 unreviewed patients of 2,740 on the register. COPD reviews rose +56.3% (England +2.8%) to 73.5% (England 76.4%). Paediatric asthma prescribing reached 1,872 items per 1,000 aged 5–19 (England 1,488, Lewes 1,696), while second-hand smoke recording was 72.2% (England 78.8%). This pattern could reflect unreviewed triggers or inhaler regimens, unverified locally and testable by clinical audit.

    Cancer register and children's immunisation

    Cancer QOF prevalence is 4.6% (1,670 patients; England 3.8%, Lewes 5.6%). For childhood immunisations in Q1 2025/26, MMR dose 1 coverage at 24 months is 89.7% (England 88.3%), below the 95.0% target by 5.3 pp. At age 5, MMR dose 2 coverage is 90.7% (England 82.8%) with a 3.7 pp difference from dose 1 (94.4%), while 4-in-1 pre-school booster coverage is 89.8%.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months92.3%

    England 91.0%

    6-in-1 complete primary course at 24 months93.8%

    England 92.2%

    MMR dose 1 at 24 months89.7%

    England 88.3%

    MMR dose 2 at age 590.7%

    England 82.8%

    4-in-1 pre-school booster at age 589.8%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    58.5%

    Sussex ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,360

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Sussex ICBEnglandNo usable stageStaged cancers
    Prostate56.6%53.2%19%1,668
    Breast86.1%85.4%23%1,400
    Bowel49.8%47.0%26%1,133
    Lung30.3%33.8%15%1,058
    Skin cancer95.3%87.8%17%698

    In NHS Sussex ICB, 58.5% of staged cancers (4,799 of 8,209) were diagnosed at stage 1 or 2 in 2022, 16.5 pp below the 75.0% national ambition, although above England (55.3%). Known-stage data covered 64.3% of 12,766 registered cases; ICB figures reflect system pathways rather than PCN performance. Reaching 75.0% would require about 1,360 extra early-stage diagnoses across the ICB. Locally, cervical screening uptake among women aged 25-49 is 68.1% (England 66.8%, Lewes 69.8%) but fell 3.8% over 2023 to 2025 (England -1.0%), down to 64.7% at Chapel Street Surgery.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026 (provisional), University Hospitals Sussex NHS Foundation Trust achieved 65.2% on the 62-day cancer referral to treatment standard (standard 85.0%), below East Sussex Healthcare NHS Trust (67.0%), Maidstone and Tunbridge Wells NHS Trust (87.4%), NHS Surrey and Sussex Integrated Care Board (71.5%), and England (71.2%). On the 28-day faster diagnosis standard (standard 75.0%), the trust reached 74.0%, below East Sussex Healthcare NHS Trust (84.2%), Maidstone and Tunbridge Wells NHS Trust (81.8%), and both the ICB and England (79.3%). Diagnostic 6+ week waits reached 12.9% overall, with colonoscopy at 39.3% (East Sussex Healthcare NHS Trust 0.7%, England 30.8%).

    Pathways within standard (%)SussexEast Sussex HealthcareMaidstone and Tunbridge WellsSurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)74.0184.2081.7879.2979.32
    31-day treatment (96%)76.7998.1998.3590.4592.50
    62-day referral to treatment (85%)65.2067.0487.4371.5171.16
    Diagnostic waits over 6 weeks (%)SussexEast Sussex HealthcareMaidstone and Tunbridge WellsEngland
    MRI5.626.480.9221.40
    CT8.570.480.519.92
    Echocardiography0.3921.942.5728.48
    Colonoscopy39.350.7419.8030.83
    Gastroscopy20.020.3124.0329.02
    All 15 DM01 tests12.955.276.4223.14
    Community services activityEast Sussex residentsSurrey and Sussex ICB
    Care contacts100,740309,615
    Referrals17,28566,930
    Patients with a contact25,88085,660

    Community services (residents of East Sussex), Jun 2026 (provisional). In June 2026 (provisional), community health services recorded 105,045 care activities and 100,740 contacts for East Sussex residents, alongside 316,320 activities and 309,615 contacts across NHS Surrey and Sussex Integrated Care Board. Contacts with adults aged 65+ accounted for 68% of the borough residents' total (68,465 contacts). These experimental figures reflect broad system activity rather than unique PCN patient contacts.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Patient experience spans 14.9 pp across practices, alongside marked variations in access

    In 2025/26, QOF overall achievement reached 94.0% at Havenshealth, 91.1% at Quayside Medical Practice, and 90.2% at Chapel Street Surgery (England 92.5%). Vaccination and immunisation achievement showed wider variation, spanning 13.9 pp from 43.5% at Chapel Street Surgery to 57.4% at Havenshealth (England 55.2%). High overall scores may mask specific preventive delivery gaps across practices.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Havenshealth1090.042.0%80.5%74.0%
    Quayside Medical1099.250.1%73.2%73.8%
    Chapel Street10511.448.9%66.7%59.1%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNLewesAssetPCNLewes
    Care homes (catchment)10 (161 beds)n/aSchools (catchment)25n/a
    Children's centres12Places of worship2476
    Libraries13Homelessness support (VCS)0no data
    Primary schools (LA maintained)516Primary academies49
    Special schoolsn/a2

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    CVD treatment and prescribing review

    Hypertension treatment to target is 64.6% (England 70.3%) across 6,479 patients; QRISK >= 20% lipid therapy is 56.3% (England 63.6%); 2026 lipid-modifying prescribing costs £2.50 per item vs £1.86 in England (£39,457 more across 61,651 items). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 2

    Asthma annual review and prescribing recall

    Asthma review coverage is 65.5% (England 65.7%, Lewes 57.0%), leaving an estimated 945 unreviewed of 2,740 patients; 5-19 prescribing is 1,872 items per 1,000 (England 1,488) and second-hand smoke recording is 72.2% (England 78.8%). Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 3

    Stroke and dementia register validation

    Over 2023 to 2025, dementia prevalence fell 11.1% (England +6.0%; 309 patients, 0.8% vs Lewes 1.1%, gap -26 to +96) and stroke fell 1.0% (England +2.3%; 819 patients, 2.2% vs Lewes 2.6%, gap -136 to +135). Low cost, quick to run.

    Evidence base: the stroke/TIA register is the cohort for AF anticoagulation and blood-pressure control (pre-stroke prevention) as well as hyperacute care; practices well below expected prevalence are the case-finding list, and the pre-stroke prevention gap concentrates in deprived practices.

    Policy anchor: Core20PLUS5 (CVD); NHS CVD ambitions to 2029.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Older adult care coordination (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Targeted Core20 practice outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI health check audit (p4)Smoking cessation support and treatment offered to patients with certain conditions (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Hypertension treatment review (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Childhood immunisation recall (p6)MMR dose 1 coverage at 24 months10YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Practice access and triage review (p9)GPPS good overall experience of the practice10YHP, hospital to communityPractice
    Option 1 · CVD treatment and prescribing review (p12)Hypertension register · Hypertension patients treated to target · Patients with QRISK ≥ 20% treated with lipid lowering therapyCore20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Option 2 · Asthma annual review and prescribing recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Asthma management items prescribed per 1000 5-19 PopulationCore20PLUS5 respiratoryPCN
    Option 3 · Stroke and dementia register validation (p12)Stroke register · Stroke: QOF prevalence · Dementia registerCore20PLUS5 CVD · CVDPREVENT · SSNAP · 66.7% diagnosis ambition · 95% care plan 2027PCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15